Research & Studies
CA Clinics recognises the vitality of safe and effective care as Australia’s medical cannabis space continues to advance and government regulations evolve with time.
That’s why we have supported a number of research and study initiatives to offer viable options for patients struggling to attain desired outcomes from more traditional approaches.
Medicinal cannabis research in Australia
CA Clinics hosts a number of medicinal cannabis research and study initiatives in conjunction with national industry names.
We have partnered with Applied Cannabis Research, providing our patients with the opportunity to contribute to industry advancements by being a part of research studies.
CA Clinics is involved in medical cannabis research by:
- Conducting its own observational study: the CACOS study
- By acting as a participating site for external studies in the medicinal cannabis space.
Findings of these studies play an important part in helping develop medicinal cannabis treatments in Australia and better informing healthcare professionals about when and how to use these treatments.
Medicinal cannabis observational study
Applied Cannabis Research
Applied Cannabis Research (ACR) is a contract research organisation specialising in clinical research studies in the field of medicinal cannabis. ACR is currently facilitating a range of observational studies into various conditions for patients being prescribed medicinal cannabis products.
Working with interested companies, authorities and clinicians, Applied Cannabis Research is staffed with academics, researchers and clinicians working in the field of medicinal cannabis.
Both of these studies are focused on collecting data from patients related to the dose of medical cannabis therapies and care, adverse events they may be experiencing and other health-related outcome measures that can be used to determine how well patients are responding to medicinal cannabis treatment.
Both studies include patients with different conditions including, chronic pain, epilepsy, multiple sclerosis, palliative care and nausea and vomiting.
If you are interested in being contacted by ACR about new research opportunities, express your interest now.